A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density

Clinical trial NCT00515463 · COMPLETED

Trial details

NCT number: NCT00515463
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Low Bone Mineral Density Osteopenia Osteoporosis

Start date: 2007-05-01
Primary completion: 2008-03-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.